Cluster analysis of clinical manifestations assigns systemic lupus erythematosus-phenotype subgroups: a multicentre study on 440 patients

2024-12-1

Discontinuation of infliximab leading to auditory loss in a patient with Cogan syndrome: A case report

2024-12-1

Points to consider for unmet needs in axial spondyloarthritis. Proceedings of the French spondyloArthritiS Taskforce workshop

2024-12-1

Clinically suspect arthralgia and rheumatoid arthritis: patients’ perceptions of illness

2024-12-1

Systemic autoinflammatory manifestations in patients with spondyloarthritis

2024-9-1

Musculoskeletal ultrasound findings in adult-onset Still’s disease: A case series

2024-9-1

The determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia are mostly objective and in line with the recommendations. Results of a cross-sectional survey-based study using a mixed (qualitative and quantitative) approach to help rheumatologists in their daily practice

2024-9-1

Progression of multiple vertebral fractures after Denosumab discontinuation under treatment with Romosozumab. A case-report

2024-9-1

Targeted therapies for uveitis in spondyloarthritis: A narrative review

2024-9-1

Intense symptoms of pain are associated with poor sleep, fibromyalgia, depression and sleep apnea in patients with rheumatoid arthritis and psoriatic arthritis. A register based study

2024-9-1

Standardized Reporting for Systematic Global Evaluation of Axial Spondyloarthritis: An Evidence-Based and Consensus-Driven Initiative

2024-9-1

Sacro iliac osteochondritis

2024-9-1

Current smoking is associated with lower prevalence of uveitis and peripheral arthritis in males, but not females, with axial spondyloarthritis

2024-9-1

Paraspinal schwannoma

2024-9-1

Assessment of Social Deprivation and Socioeconomic Factors in Patients with Giant Cell Arteritis

2024-9-1

Corrigendum to “Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies: An up-to-date narrative review” [Joint Bone Spine. 90 (2023) 105598]

2024-9-1

Translation and cross-cultural adaptation of the modified Short Questionnaire to Assess Health-enhancing physical activity (mSQUASH) into French language

2024-9-1

Skeletal Muscle Mass and Quality in Gout Patients Versus Non-Gout Controls: A Computed Tomography Imaging Study

2024-9-1

Navigating the Complexities of Difficult-to-Treat Axial Spondyloarthritis

2024-8-1

Virtual Reality as a Treatment for Chronic Musculoskeletal Pain Syndromes

2024-8-1

Contents

2024-7-1

Ultrasound findings in secondary hypertrophic osteoarthropathy

2024-7-1

“If I have Sjögren's syndrome, I want to know it as early as possible”: The perspective of first-degree relatives of patients with Sjögren's syndrome from an international survey

2024-7-1

VEXAS syndrome: An update

2024-7-1

Association of axial spondyloarthritis and IgA vasculitis: Report of two cases

2024-7-1

Comment on: "J-shaped association of serum uric acid concentrations with all-cause mortality in individuals with osteoarthritis: A prospective cohort study" by Zhao et al, Joint Bone Spine 2024;91:105679

2024-7-1

Osteochondrosis of the primary ossification center (Kohler’s Disease) of the Patella

2024-7-1

Saddle nose deformity in eosinophilic granulomatosis with polyangiitis

2024-7-1

Hand osteoarthritis: A fresh look

2024-7-1

Update on targeted treatments for ANCA-associated vasculitis

2024-7-1

VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease

2024-7-1

Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal

2024-7-1

Facet joint involvement in the inflammatory rheumatic disease

2024-7-1

Editorial Board

2024-7-1

High-resolution peripheral quantitative computed tomography for the assessment of acro-osteolysis and calcinosis in patients with systemic sclerosis

2024-7-1

McCune-Albright syndrome: Beyond classical craniofacial deformities

2024-7-1

Effect of systemic lupus erythematosus on the ovarian reserve: A systematic review and meta-analysis

2024-7-1

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – does it depend on the reason for withdrawal from the previous treatment?

2024-7-1

Interest in various treatments for osteoarthritis among the French population: a Google Trends analysis

2024-7-1

Evolution of FIB-4 score in SpA and PsA patients taking anti-TNF or anti-IL17

2024-7-1

A pilot study of refractory enthesitis treated with CO2 laser in spondyloarthritis and psoriatic arthritis

2024-7-1

Can we consider a pre-clinical state of axial spondyloarthritis?

2024-7-1

Hurdles in new drug development in rheumatic diseases

2024-7-1

NSAID: Current limits to prescription

2024-7-1

Hip involvement and its impact on treatment decision in patients with Axial Spondyloarthritis; Treasure experience

2024-7-1

Reconsidering Diagnostic Practices: Sarcopenia Diagnosis in Gout Revisited. Comment on: “Skeletal muscle mass and quality in gout patients versus non-gout controls: a computed tomography imaging studio‿ by Covello et al. Joint Bone Spine 2024;91:105743

2024-7-1

Double Vertebrae Kummell's Disease

2024-6-26

Chronic Pain for Rheumatological Disorders: Pathophysiology, Therapeutics and Evidence

2024-6-1

From Imaging Findings to Fracture Liaison Services: is the referral pathway for vertebral fragility fractures effective?

2024-6-1

Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data

2024-5-1